CPC Main Group
C12Y 104/00 Oxidoreductases acting on the CH-NH2 group of donors (1.4)
Filing statistics
CPC C12Y 104/00 belongs to the parent subclass C12Y, which recorded 144,590 patent applications worldwide between 2013 and 2023. Annual filings grew from 9,773 in 2013 to 11,938 in 2023 (+22%), peaking at 15,970 applications in 2021. The most active applicants in class C12 are HARVARD UNIVERSITY (8,321 applications), CHINESE ACADEMY OF SCIENCES (7,486 applications) and UNIVERSITY OF CALIFORNIA (7,320 applications).
Source: EPO PATSTAT, worldwide filings
9 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12Y 104/01 with NAD+ or NADP+ as acceptor (1.4.1)
- C12Y 104/02 with a cytochrome as acceptor (1.4.2)
- C12Y 104/03 with oxygen as acceptor (1.4.3)
- C12Y 104/04 with a disulfide as acceptor (1.4.4)
- C12Y 104/05 with a quinone or similar compound as acceptor (1.4.5)
- C12Y 104/07 with an iron-sulfur protein as acceptor (1.4.7)
- C12Y 104/09 with a copper protein as acceptor (1.4.9)
- C12Y 104/98 with other, known, acceptors (1.4.98)
- C12Y 104/99 with other acceptors (1.4.99)
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692